EurekAlert (press release)Combo immunotherapy may herald new standard of care for kidney cancerEurekAlert (press release)DALLAS – July 05, 2017 – Combination therapy with two immunotherapy drugs produces an unprecedented doubling of response rates from… Continue reading
Combo immunotherapy may herald new standard of care for kidney cancerMedical XpressCombination immunotherapy with nivolumab and ipilimumab as tested in the kidney cancer study described here is already FDA-approved for treatment of melanoma, and is bei… Continue reading
MIT Technology Review |
Your Pet’s Disease Could Be Cured by Gene Therapy
MIT Technology Review For decades, gene therapy has been envisioned as a way to cure disease by introducing new genetic material into people’s DNA. The technology is finally showing success in patients, with treatments moving closer to regulatory approval in the U.S. (see … |
Ovarian Cancer News Today |
Celyad’s CAR T-cell Therapy Shows Promise in 2 Patients with Advanced Colorectal Cancer
Ovarian Cancer News Today Celyad’s NKR-2 CAR T-cell therapy is a personalized therapy that isolates a patient’s own T-cells, a type of white blood cell, and adds a protein called NKG2D to the cells. NKG2D helps T-cells recognize and kill tumor cells. Once they are “armed” with … |